English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Engineering a protein-based nanoplatform as an antibacterial agent for light activated dual-modal photothermal and photodynamic therapy of infection in both the NIR i and II windows Journal article
Gao D.Y., Ji X., Wang J.L., Wang Y.T., Li D.L., Liu Y.B., Chang K.W., Qu J.L., Zheng J., Yuan Z.. Engineering a protein-based nanoplatform as an antibacterial agent for light activated dual-modal photothermal and photodynamic therapy of infection in both the NIR i and II windows[J]. Journal of Materials Chemistry B, 2018, 6(5), 732-739.
Authors:  Gao D.Y.;  Ji X.;  Wang J.L.;  Wang Y.T.;  Li D.L.; et al.
Favorite | TC[WOS]:44 TC[Scopus]:45 | Submit date：2018/12/17
The Chinese first-episode schizophrenia trial: Background and study design Journal article
Han X., Yuan Y.B., Yu X., Zhao J.P., Wang C.Y., Lu Z., Yang F.D., Dong H., Wu Y.F., Ungvari G.S., Xiang Y.T., Chiu H.F.K.. The Chinese first-episode schizophrenia trial: Background and study design[J]. East Asian Archives of Psychiatry, 2014, 24(4), 169-173.
Authors:  Han X.;  Yuan Y.B.;  Yu X.;  Zhao J.P.;  Wang C.Y.; et al.
Favorite |  | Submit date：2018/12/18
Antipsychotic agents  Clinical trial  Schizophrenia